Becker, Marc A <br/><br/>
Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth.  [electronic resource] 

 -  Molecular cancer therapeutics  Dec 2013 
 - 2909-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-13-0547  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Cell Line, Tumor<br/>Cluster Analysis<br/>Disease Models, Animal<br/>Disease Progression<br/>Female<br/>Humans<br/>Mice<br/>Neoplasm Grading<br/>Ovarian Neoplasms--drug therapy<br/>Piperidines--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proteomics<br/>Pyrroles--administration & dosage<br/>Quinazolines--administration & dosage<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Signal Transduction<br/>Triazines--administration & dosage<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays